Final Up to date on June 23, 2022 by GlobeNewsWire
IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) right this moment introduced that the Firm’s CEO will take part on the 2022 BTIG Biotechnology Convention being held in individual in New York Metropolis on Monday, August eighth and Tuesday August ninth, 2022. The Firm’s CEO may even be accessible for in-person one-on-one conferences on the convention.
About Biomerica NASDAQ: BMRA)
Biomerica, Inc. (www.biomerica.com) is a worldwide biomedical expertise firm that develops, patents, manufactures and markets superior diagnostic and therapeutic merchandise used on the point-of-care (in house and in physicians’ workplaces) and in hospital/scientific laboratories, for detection and/or therapy of medical circumstances and ailments. The Firm’s merchandise are designed to reinforce the well being and well-being of individuals, whereas lowering complete healthcare prices. Biomerica primarily focuses on gastrointestinal and inflammatory ailments the place the Firm has a number of diagnostic and therapeutic merchandise in growth.
John Nesbett / Jennifer Belodeau
IMS Investor Relations